AI assistant
NEOGENOMICS INC — Director's Dealing 2017
May 2, 2017
32227_dirs_2017-05-02_91cc8063-69e3-4689-b659-728a428e8cca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-04-28
Reporting Person: BRODIE STEVEN G. (Vice President of Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-28 | Stock Option (Right to Buy) | $7.52 | A | 50000 | Acquired | 2022-04-28 | Common Stock (50000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 25953 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.45 | 2019-03-05 | Common Stock (20000) | 20000 | Direct |
| Stock Option (Right to Buy) | $4.78 | 2020-05-04 | Common Stock (120000) | 120000 | Direct |
| Stock Option (Right to Buy) | $7.15 | 2021-04-20 | Common Stock (100000) | 100000 | Direct |
Footnotes
F1: On March 5, 2014, Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
F2: On May 4, 2015, Dr. Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
F3: On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.